vs

Side-by-side financial comparison of MACROGENICS INC (MGNX) and RMR GROUP INC. (RMR). Click either name above to swap in a different company.

RMR GROUP INC. is the larger business by last-quarter revenue ($66.7M vs $41.2M, roughly 1.6× MACROGENICS INC). On growth, MACROGENICS INC posted the faster year-over-year revenue change (113.0% vs 40.8%).

MacroGenics Inc is a clinical-stage biopharmaceutical firm specializing in the research and development of novel immunotherapies for cancer and autoimmune disorders. Its core product pipeline centers on monoclonal antibody-based treatments, with key programs targeting solid tumors and hematological malignancies, supported by partnerships with global pharmaceutical partners.

RMR Group Inc. is a U.S.-headquartered alternative asset management firm specializing in real estate and real estate-related investments. It operates across commercial property, residential real estate, and infrastructure segments, serving institutional investors, high-net-worth individuals, and retail clients across key global markets.

MGNX vs RMR — Head-to-Head

Bigger by revenue
RMR
RMR
1.6× larger
RMR
$66.7M
$41.2M
MGNX
Growing faster (revenue YoY)
MGNX
MGNX
+72.3% gap
MGNX
113.0%
40.8%
RMR

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
MGNX
MGNX
RMR
RMR
Revenue
$41.2M
$66.7M
Net Profit
$12.2M
Gross Margin
Operating Margin
-29.3%
48.1%
Net Margin
18.3%
Revenue YoY
113.0%
40.8%
Net Profit YoY
91.1%
EPS (diluted)
$-0.23
$0.71

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MGNX
MGNX
RMR
RMR
Q4 25
$41.2M
$66.7M
Q3 25
$72.8M
Q2 25
$22.2M
Q1 25
$13.2M
Q4 24
$19.4M
Q3 24
$110.7M
Q2 24
$10.8M
Q1 24
$9.1M
Net Profit
MGNX
MGNX
RMR
RMR
Q4 25
$12.2M
Q3 25
$16.8M
Q2 25
$-36.3M
Q1 25
$-41.0M
Q4 24
Q3 24
$56.3M
Q2 24
$-55.7M
Q1 24
$-52.2M
Gross Margin
MGNX
MGNX
RMR
RMR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
98.8%
Q3 24
99.8%
Q2 24
98.4%
Q1 24
97.0%
Operating Margin
MGNX
MGNX
RMR
RMR
Q4 25
-29.3%
48.1%
Q3 25
25.6%
Q2 25
-165.3%
Q1 25
-323.1%
Q4 24
-273.0%
Q3 24
48.9%
Q2 24
-538.9%
Q1 24
-590.4%
Net Margin
MGNX
MGNX
RMR
RMR
Q4 25
18.3%
Q3 25
23.1%
Q2 25
-163.0%
Q1 25
-311.1%
Q4 24
Q3 24
50.9%
Q2 24
-515.6%
Q1 24
-573.3%
EPS (diluted)
MGNX
MGNX
RMR
RMR
Q4 25
$-0.23
$0.71
Q3 25
$0.27
Q2 25
$-0.57
Q1 25
$-0.65
Q4 24
$-0.24
Q3 24
$0.90
Q2 24
$-0.89
Q1 24
$-0.84

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MGNX
MGNX
RMR
RMR
Cash + ST InvestmentsLiquidity on hand
$57.2M
$49.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$55.6M
$232.7M
Total Assets
$256.8M
$687.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MGNX
MGNX
RMR
RMR
Q4 25
$57.2M
$49.3M
Q3 25
$80.1M
Q2 25
$130.7M
Q1 25
$145.6M
Q4 24
$182.8M
Q3 24
$179.6M
Q2 24
$83.9M
Q1 24
$80.4M
Stockholders' Equity
MGNX
MGNX
RMR
RMR
Q4 25
$55.6M
$232.7M
Q3 25
$67.0M
Q2 25
$46.6M
Q1 25
$79.1M
Q4 24
$116.1M
Q3 24
$120.1M
Q2 24
$57.8M
Q1 24
$106.2M
Total Assets
MGNX
MGNX
RMR
RMR
Q4 25
$256.8M
$687.1M
Q3 25
$270.8M
Q2 25
$245.4M
Q1 25
$224.6M
Q4 24
$261.7M
Q3 24
$264.5M
Q2 24
$201.1M
Q1 24
$248.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MGNX
MGNX
RMR
RMR
Operating Cash FlowLast quarter
$43.0M
$10.7M
Free Cash FlowOCF − Capex
$42.8M
FCF MarginFCF / Revenue
103.8%
Capex IntensityCapex / Revenue
0.6%
Cash ConversionOCF / Net Profit
0.88×
TTM Free Cash FlowTrailing 4 quarters
$-83.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MGNX
MGNX
RMR
RMR
Q4 25
$43.0M
$10.7M
Q3 25
$-30.2M
Q2 25
$-47.0M
Q1 25
$-46.9M
Q4 24
$-38.4M
Q3 24
$60.2M
Q2 24
$-44.5M
Q1 24
$-45.6M
Free Cash Flow
MGNX
MGNX
RMR
RMR
Q4 25
$42.8M
Q3 25
$-30.6M
Q2 25
$-47.7M
Q1 25
$-47.4M
Q4 24
$-39.0M
Q3 24
$59.6M
Q2 24
$-45.5M
Q1 24
$-47.1M
FCF Margin
MGNX
MGNX
RMR
RMR
Q4 25
103.8%
Q3 25
-42.0%
Q2 25
-214.5%
Q1 25
-359.5%
Q4 24
-201.7%
Q3 24
53.8%
Q2 24
-421.6%
Q1 24
-517.4%
Capex Intensity
MGNX
MGNX
RMR
RMR
Q4 25
0.6%
Q3 25
0.6%
Q2 25
3.2%
Q1 25
4.0%
Q4 24
3.2%
Q3 24
0.5%
Q2 24
9.6%
Q1 24
16.0%
Cash Conversion
MGNX
MGNX
RMR
RMR
Q4 25
0.88×
Q3 25
-1.79×
Q2 25
Q1 25
Q4 24
Q3 24
1.07×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MGNX
MGNX

Revenue From Collaborative Agreements$20.3M49%
Contract Manufacturing$11.3M27%
Other$9.7M23%

RMR
RMR

Management Service Incentive$23.6M35%
Industrial Logistics Properties Trust$15.1M23%
Managed Private Real Estate Capital$11.1M17%
Office Properties Income Trust$5.6M8%
Other Private Entities$5.3M8%
RMR Residential$3.4M5%
Sonesta International Hotels Corporation$2.1M3%
Investment Advisory Management And Administrative Service$1.2M2%

Related Comparisons